The metabolic pathway leading to carboxylic acid derivatives of cannab
inoids was discovered more than twenty years ago. While these compound
s showed no cannabimimetic activity, subsequent work documented severa
l biological responses both in vitro and in vivo for the THC acids. Th
ese include inhibition of eicosanoid synthesis, antiedema effects, ant
agonism to PAF actions, inhibition of leucocyte adhesion and anti noci
ception. In this report we present data further characterizing the ana
lgesic properties of the title substance which is a potent synthetic m
ember of this group. CT3 was effective in the mouse hot plate assay at
48 degrees C showing an ED-50 of 4.31(3.37-5.83) mg/kg when administe
red i.v (10% Cremophor EL in saline). When given by gavage in peanut o
il, it resulted in 30-40% MPE (maximum possible effect) at 10 mg/kg wi
th the effect persisting for up to 5 hours. A more potent response was
observed in the mouse p-phenylquinone writhing test. When given i.v.,
it showed an ED-50 of 1.24 (0.84-1.75) mg/kg. However, no activity wa
s found with oral administration either in peanut oil or Cremophor EL.
At 10 mg/kg i.v., a 100% inhibition of the writhing response was seen
. The mouse formalin antinociception test was also studied in animals
that received CT3 (4.64 mg/kg) i.v, using three behavioral parameters
for activity. The drug showed decreases in each category when compared
with vehicle/formalin treated mice. The formalin effect showed a typi
cal two phase, time related, response in which CT3 caused a 64% reduct
ion in the early phase and a 48% reduction in the late phase in a comp
osite score of nociception. Interestingly, it did not alter motor func
tion in the rota rod procedure at 4.64 mg/kg i.v.